青春期前后卵母细胞冷冻保存:从实验到新兴实践
本文为叙述性综述,评估青春期前后卵母细胞冷冻保存作为保留生殖潜力选项的已发表临床数据。已发表数据有限但支持该技术通过控制性卵巢刺激或卵巢组织冷冻时体外成熟等方式在青春期前后(尤其月经初潮后)的可行性,但卵母细胞非整倍体风险、卵巢刺激长期影响及心理社会影响尚未评估,需长期随访研究明确安全性和生殖有效性。
要点
- 已发表数据支持青春期前后卵母细胞冷冻保存的可行性,尤其月经初潮后。
- 卵母细胞的非整倍体风险及卵巢刺激长期影响尚未评估。
- 需长期随访研究明确该技术的安全性和生殖有效性。
核心结论
- 尽管有局限性,已发表数据支持青春期前后卵母细胞冷冻保存在各种良恶性疾病中的可行性,但需长期随访研究明确安全性和生殖有效性。
研究设计与样本
- 叙述性综述,评估已发表的关于青春期前后卵母细胞冷冻保存作为保留生殖潜力选项的临床数据。
主要发现
- 卵母细胞冷冻保存可通过控制性卵巢刺激(冷冻成熟卵母细胞或未成熟卵母细胞体外成熟)或卵巢组织冷冻时体外成熟获取。
- 这些技术具有不同水平的临床成熟度和成功证据。
- 已发表临床数据有限,但支持通过不同技术在青春期前后(尤其月经初潮后)进行卵母细胞冷冻保存的可行性。
- 这些卵母细胞的生殖潜力(包括非整倍体风险)尚未评估。
- 卵巢刺激的潜在长期影响及年轻人群的心理社会影响仍存在不确定性。
临床怎么用
- 青春期前后卵母细胞冷冻保存可作为保留生殖潜力的选项,尤其月经初潮后。
- 需关注卵巢刺激的长期影响及心理社会影响。
- 应开展长期随访研究以明确安全性和生殖有效性。
局限性
- 已发表临床数据有限。
- 卵母细胞的生殖潜力及非整倍体风险尚未评估。
- 卵巢刺激的长期影响及心理社会影响不确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the published clinical data on oocyte cryopreservation as an option for preserving the reproductive potential of girls before and during puberty, while addressing the research gaps, recent advancements, and future directions in the field. DESIGN: Narrative review. SUBJECTS: Not applicable. INTERVENTION (FOR RCT) OR EXPOSURE (FOR OBSERVATIONAL STUDIES): Not applicable. MAIN OUTCOME MEASURES: Not applicable. RESULTS: Oocyte cryopreservation to preserve reproductive potential in various benign and malignant conditions can be obtained through controlled ovarian stimulation (with cryopreservation of mature oocytes or in vitro maturation of immature oocytes) or in vitro maturation at the time of ovarian tissue cryopreservation. These techniques have different levels of clinical maturity and evidence of success. Published clinical data, though limited, support the feasibility of oocyte cryopreservation through these varying techniques before and during puberty, and especially after menarche. The reproductive potential of these oocytes, including the risk for aneuploidy, however, has not been evaluated, and uncertainties regarding potential long-term effects of ovarian stimulation and the psychosocial impact in young populations remain. As the use of oocyte cryopreservation before and during puberty continues to expand, long-term follow-up studies will be essential to define both safety and reproductive effectiveness. The future of fertility preservation for girls before and during puberty will be defined not by any single clinical innovation, such as oocyte cryopreservation, but by the convergence of advances across encapsulated in vitro follicle growth, artificial ovary engineering, neoadjuvant fertoprotective pharmacology targeting the checkpoint kinase 2-Tap63α axis and complementary DNA damage response pathways, and broader emerging biotechnologies, which are described here. CONCLUSION: Despite limitations, published data support the feasibility of oocyte cryopreservation before and during puberty in various benign and malignant conditions. However, long-term follow-up studies are required to define safety and reproductive effectiveness.
引用
- Salama M, Gomez-Lobo V, Gracia C, et al. Oocyte cryopreservation before and during puberty: experimental to emerging practice. Fertil Steril. 2026. PMID: 42874763. doi:10.1016/j.fertnstert.2026.10.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。